Vimarsana
Biggest News Aggregation in the World

Ran Jin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ran Jin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ran Jin Today - Breaking & Trending Today

Strong Satisfaction Levels with Adalimumab Biosimilar Seen Among Initiators, Switchers with IBD - Vimarsana News

Strong Satisfaction Levels with Adalimumab Biosimilar Seen Among Initiators, Switchers with IBD

Published: December 6, 2023

This new analysis on IBD patients initiating biologic therapy with the biosimilar ABP 501 indicates that the drug’s lower cost and efficacy may lead to greater use.

Source: hcplive.com
Related Topics:
Thousand OaksUnited StatesUnited KingdomAmgen IncDisease Specific ProgrammeRan JinSpecific ProgrammeWork ProductivityActivity ImpairmentInflammatory Bowel DiseaseAbp 101
Study Observes Low Switch Back Rates in Infliximab Biosimilar ABP 710 - Vimarsana News

Study Observes Low Switch Back Rates in Infliximab Biosimilar ABP 710

Published: May 14, 2023

During the study follow-up period, 74.5% of switchers and 51.3% of infliximab-naïve patients remained on ABP 710 treatment without a treatment gap.

Source: hcplive.com
Related Topics:
Drug AdministrationAmgen IncRan JinDigestive Disease Week